Press-release for stocks related to treatment

Prices are updated after-hours

| 15.26% | O: 0.62% H: 2.74% C: 1.86%
covid-19 fda granted treatment pharmaceuticals designation fast track designation

| 10.45% | O: 0.3% H: 2.98% C: 1.79%
covid-19 treatment hepatitis research conference bemnifosbuvir antiviral favorable international

| -19.04% | O: -1.53% H: 4.0% C: 1.78%
covid-19 treatment pharmaceuticals antiviral trial

| -37.29% | O: 0.85% H: 3.19% C: 1.68%
at-752 treatment pharmaceuticals meeting dengue phase 1

Atea Pharmaceuticals Announces U.S. FDA Fast Track Designation Granted to AT-752 for Treatment of Dengue
Published: 2022-09-26 (Crawled : 11:00) - ir.ateapharma.com
AVIR | $3.705 -0.67% -0.67% 200K

| -36.21% | O: -0.52% H: 6.07% C: -4.68%
at-752 treatment fda pharmaceuticals designation granted qdengue fast track designation

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.